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Introduction
Systemic lupus erythematosus (SLE) is an autoimmune
disease characterized by immune dysregulation result-
ing in the production of antinuclear antibody (ANA),
generation of circulating immune complexes, and acti-
vation of the complement system.1 Its clinical manifes-
tations are diverse, with musculoskeletal and cutaneous
manifestations being the most common.2 The most
common ophthalmic presentation in patients with SLE
is retinopathy with microangiopathy, which presents
with cotton wool spots with or without intraretinal
hemorrhage.2 However, severe vaso-occlusive retinopa-
thy as the initial manifestation of SLE is relatively rare.3
There have been fewer than 50 patients previously
reported in the literature,3–7 and there has been no
previous case described in Taiwan. We report a 16-
year-old female who suffered from sudden vision loss
associated with severe vaso-occlusive retinopathy, which
led to the diagnosis of SLE.
Case Report
This 16-year-old female, who lived in Ping Tung, was
well previously. She suffered from sudden onset of
bilateral vision loss in the interval of 1 week and was
referred to our clinic on January 20, 2005. Her best cor-
rected visual acuity was counting fingers at 30cm in the
right eye and 6/60 in the left eye. The anterior segment
and vitreous were clear. No tear film insufficiency or
scleral inflammation was noted. Fundus examination
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showed bilateral extensive cotton wool spots (Figure 1).
Fluorescence angiography of the right eye revealed
complete obliteration of the macular capillary and wide-
spread occlusion in the smaller vessels, with only the
larger retinal vessels showing perfusion (Figure 2A).
There was a similar picture in the left eye, with partial
sparing of the vascular network around the central
macula (Figure 2B).
Laboratory studies disclosed leukopenia. Elevated
ANA titer with a speckled (1:1,280) pattern was also
noted. The anti-double-stranded DNA (anti-ds DNA)
antibody titer was 9.13 µg/mL (normal, < 7 µg/mL),
and complement levels of C3 and C4 were reduced.
Malar rashes, oral ulcers, and bilateral knee joint tender-
ness were also noted. However, the tests for anticardi-
olipin antibodies and lupus anticoagulant antibodies
were negative. SLE was diagnosed according to the
revised American College of Rheumatology (ACR)
classification criteria.8
Intravenous steroid pulse therapy was prescribed
immediately. Visual acuity of the left eye improved to
6/10 after treatment. However, there was no visual
improvement in the right eye. Thereafter, the patient’s
condition stabilized under oral antimalarial drugs and
steroid prescribed by a rheumatologist.
Four months later, retinal neovascularization devel-
oped in both eyes. Although panretinal photocoagu-
lation was applied to both retinas, the disease continued
to progress. Seven months later, advanced tractional
retinal detachment of the right eye and vitreous hem-
orrhage of the left eye occurred. The patient suffered
from bilateral vision loss again. After undergoing cry-
oretinopexy of the right eye and intravitreous tissue
plasminogen activator (t-PA) injection of the left eye,
the visual acuity of the right eye remained hand move-
ment only at 10 cm, but that of the left eye returned
to 6/10. She has been regularly followed-up at the
ophthalmologic and rheumatologic clinics for more
than 2 years; her ocular and systemic conditions have
remained stable (Figure 3).
Discussion
SLE is a chronic, usually life-long, potentially fatal
autoimmune disease characterized by unpredictable
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Figure 1. Color fundus pictures at presentation showed diffuse, confluent cotton wool spots predominantly in the posterior pole.
A B
Figure 2. Fluorescence angiography revealed complete obliteration of the macular capillary and widespread occlusion in smaller vessels,
with only the larger retinal vessels showing perfusion. The right eye (A) was more severe than the left eye (B).
exacerbations and remissions with protean clinical mani-
festations. In SLE, there is a predilection for clinical
involvement of the joints, skin, kidney, brain, eye, serosa,
lung, heart and gastrointestinal tract. It is most com-
mon in women of child-bearing age. The etiology of
SLE remains unknown. Disease manifestations result
from recurrent vascular injury due to immune complex
deposition, leukothrombosis, or thrombosis.2
Severe tear deficiency, scleral inflammation, and
retinal vasculopathy are hallmarks of ophthalmic involve-
ment in SLE. The most common fundus findings in
SLE are cotton wool spots, retinal hemorrhage, vascu-
lopathy, and optic disc edema.9–11 Severe vaso-occlusive
retinopathy is a relatively rare form of retinopathy in
SLE that often affects the smaller retinal arteries and
arterioles. There have been fewer than 50 patients
reported previously.3–7 About 70% of these patients were
affected bilaterally.3–7 Diffuse and widespread arterio-
lar or branch arterial occlusion, capillary non-perfusion,
and severe retinal ischemia often resulted. The patho-
logic basis for this severe vaso-occlusive retinopathy
has been considered an immune complex-mediated
vasculopathy, based on previous reports of immune
complex deposition in retinal vessels in SLE. Rather
than a true inflammatory vasculitis, the retinal vascular
disease is thought to stem from fibrinoid degeneration
with necrosis of the vessel walls.12–14 Histologic find-
ings have described fibrinoid change with thrombosis
in the vessel walls without evidence of inflammation.15
However, the precise nature of these occlusive lesions
remains unclear.
Since the ocular complications of SLE are gener-
ally associated with active disease elsewhere in the body,
control of the systemic disease may lead to resolution
of the ocular manifestations. Some oral medications
(e.g. nonsteroidal anti-inflammatory agents, antima-
larial therapy, immunosuppressive agents, antiplatelet
treatment, steroids) may be helpful in the treatment of
SLE.12 Systemic therapy with steroid is required when
severe manifestations of SLE such as vaso-occlusive
retinopathy are present.12 In this case, intravenous ste-
roid pulse therapy was prescribed in the beginning 
to stabilize the acute stage of the disease. Thereafter,
antimalarial drugs and low-dose steroid were given to
control the disease activity of SLE.
Treatment of SLE retinopathy is aimed at prevent-
ing complications arising from neovascularization. A
significant factor affecting visual outcome is the high
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Figure 3. Color fundus pictures (upper) and fluorescence angiography (lower) 2 years later. Tractional retinal detachment of the right eye
and panretinal photocoagulation over the left eye were observed.
rate of neovascularization and vitreous hemorrhage
arising from retinal ischemic events. Panretinal pho-
tocoagulation and vitrectomy have been found to be
useful in preserving vision.12 In this case, the early inter-
vention with bilateral panretinal photocoagulation may
be considered to have prevented complications arising
from neovascularization.
Vision loss is an important issue in vaso-occlusive
retinopathy of SLE. In 50% of SLE patients with this
type of vaso-occlusive retinopathy, visual acuity was
less than 6/20.3–7 In this case, the visual acuity of the
right eye was hand movement at 10 cm. The visual
prognosis is poor, as reported in the literature.3–7 This
case highlights the importance of timely treatment to
prevent further vision loss.
Additionally, the association between severe vaso-
occlusive retinopathy in SLE and the presence of anti-
phospholipid antibodies has been noted.9,16–19 In 50
SLE patients presenting with vaso-occlusive retinopa-
thy, more than 10 were associated with antiphospho-
lipid antibodies.8–11,16 The antiphospholipid syndrome
is well recognized in SLE. Tests for antiphospholipid
antibodies should be performed in patients with severe
vaso-occlusive retinopathy, especially if they have an
associated lupus-like syndrome or features of the anti-
phospholipid syndrome. However, the tests for anti-
phospholipid antibodies were negative in this case and
antiphospholipid syndrome could be ruled out.
In conclusion, we described a 16-year-old female
who presented with a rare but visually devastating
form of retinopathy characterized by severe extensive
retinal arteriolar occlusions. Visual acuity of the left
eye improved after treatment, but there was no visual
improvement in the right eye due to tractional retinal
detachment. This case reminds us that in patients
with severe vaso-occlusive retinopathy, a generalized
immunologic disorder, like SLE, should be taken into
consideration.
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